Clinical trial Recruiting at 1 site Observational Ages 18 to 55

Deep phenotyping to explore recovery in young adults after stroke

Official title: Young Stroke Service Deep Phenotyping: Exploring Recovery in Young Adult Survivors of Stroke

Run by The Florey Institute of Neuroscience and Mental Health · NCT07019493 · Data updated 2026-11-12

This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.

Quick facts

Study typeObservational
Ages18 Years to 55 Years
SexAll
Enrollment100 (estimated)
SponsorThe Florey Institute of Neuroscience and Mental Health
Academic / other
Locations2 sites (Heidelberg, Victoria and 1 other locations)
StatusRecruiting
StartedJuly 19, 2025
Main results expectedDecember 31, 2026
Study endsDecember 2027
Registry record updatedApril 21, 2026
Trial IDNCT07019493 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–55 who have had an acute stroke and can be recruited within one month of the event (or within three months if earlier recruitment was not possible) and who do not have severe progressive illness or major psychiatric conditions.

Probably not a fit

People with a life expectancy under 24 months, severe progressive neurological disease (e.g., advanced dementia or severe MS), or major psychiatric conditions requiring medical intervention are unlikely to gain direct benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a small, observational pilot across Melbourne hospitals enrolling up to 100 young adults with recent stroke. Participants undergo comprehensive data collection and biological sampling to create a detailed picture of their health and recovery. The study will measure feasibility outcomes such as practicality, consistency, and participant acceptability of the deep phenotyping protocol. Investigators will also explore relationships between biomarkers, demographics (age, sex), stroke type, lifestyle and environmental factors and recovery to inform larger future studies.

Why it matters

Potential benefit: If successful, this approach could help identify markers and patterns that guide more personalized recovery plans for younger stroke survivors.

How similar studies have gone: Deep phenotyping has shown promise in other neurological and vascular research, but multicenter deep phenotyping specifically focused on young stroke survivors is limited and largely exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Between 18 and 55 years.
2. Within one month of acute stroke confirmed with standard of care brain imaging or clinical diagnosis or for those for whom recruitment \<1 month of stroke is not possible they may be recruited to participate within 3-months of stroke

Exclusion Criteria:

1. Severe, intercurrent or progressive illness likely to EITHER

   1. Have a prognosis for survival under 24 months; OR
   2. In the opinion of the investigator will mask the importance to the individual participant data (e.g. severe MS, dementia, etc)
2. Major psychiatric condition requiring medical intervention

Where it's running

  • Austin Health
    Heidelberg, Victoria, Australia
    Recruiting
  • Florey Institute of Neuroscience and Mental Health, Melbourne Brain Centre
    Heidelberg, Victoria, Australia
    Not yet recruiting

Study contacts

  • Principal investigator: Vincent Thijs, MD, PhD — The Florey Institute of Neuroscience and Mental Health
  • Study coordinator: Emily Ramage, BPhysio, PhD
  • Email: emily.ramage@florey.edu.au
  • Phone: +61 3 90357000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.